EBV INFECTION

Clinical trials for EBV INFECTION explained in plain language.

Never miss a new study

Get alerted when new EBV INFECTION trials appear

Sign up with your email to follow new studies for EBV INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Completed 1

New antibody drug aims to stop deadly virus after transplant

Disease control Not yet recruiting

This study tests a new medicine called zuberitamab for people who develop an EBV infection after a stem cell transplant. EBV can cause a serious condition called PTLD, which can be fatal if not treated. The drug targets infected cells to clear the virus and prevent complications.…

Matched conditions: EBV INFECTION

Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control

Last updated May 13, 2026 15:59 UTC

EBV INFECTION

Get alerted when new EBV INFECTION trials appear

New antibody drug aims to stop deadly virus after transplant